Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Alpha-melanocyte-stimulating hormone helps manage skin inflammation and protect against UV damage.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

New wound healing method using nanoparticles in a gel speeds up healing and reduces infection and inflammation.

Bone marrow-derived stem cells greatly improve skin wound healing in rats.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Zebrafish help understand genetic causes of skin pigment disorders like albinism.

Wrinkled skin in Xiang pigs is linked to gene changes related to oxidative stress and the extracellular matrix.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Drug repurposing shows promise for treating many medical conditions.

PRP is an effective and safe treatment for alopecia areata.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Combining polymers and lipids may improve antioxidant delivery for wound healing, but practical challenges remain.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.